We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Phase-shifted tACS can modulate cortical alpha waves in human subjects

    In the present study, we investigated traveling waves induced by transcranial alternating current stimulation in the alpha frequency band of healthy...

    Alexandre Aksenov, Malo Renaud-D’Ambra, ... Anne Beuter in Cognitive Neurodynamics
    Article 29 August 2023
  2. A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects

    Background

    Iberdomide is a novel potent cereblon modulator (CELMoD ® ) agent, which is currently under clinical development for hematological...

    Yiming Cheng, **aomin Wang, ... Yan Li in European Journal of Drug Metabolism and Pharmacokinetics
    Article 23 March 2024
  3. Regulatory, Ethical and Political Challenges of Experimentation with LSD on Human Subjects

    The inventor of LSD, Albert Hoffmann, himself referred to his most famous discovery as his ‘problem child’. In the first part of this chapter, we...
    Kristof Janos Bodnar, Szabina Peter in Integrity of Scientific Research
    Chapter 2022
  4. Observation of Aerosol Generation by Human Subjects During Cardiopulmonary Exercise Testing Using a High-Powered Laser Technique: A Pilot Project

    Purpose

    Human respiratory aerosols may have important implications for transmission of pathogens. The study of aerosol production during vigorous...

    Christopher M. Varga, Keith J. Kwiatkowski, ... Stephen M. Paridon in Journal of Medical and Biological Engineering
    Article 23 January 2022
  5. Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits

    In an effort to minimize protocol noncompliance in neurological research studies that can potentially compromise patient safety, delay completion of...

    Matthew J. Gooden, Gina Norato, ... Lauren Reoma in Neurotherapeutics
    Article 21 January 2021
  6. CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease

    Background

    Efavirenz is an anti-HIV drug, and cytochrome P450 46A1 (CYP46A1) is a CNS-specific enzyme that metabolizes cholesterol to...

    Alan J. Lerner, Steven E. Arnold, ... Irina A. Pikuleva in Alzheimer's Research & Therapy
    Article Open access 29 December 2022
  7. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    The study of psychiatric and neurological diseases requires the substrate in which the disorders occur, that is, the nervous tissue. Currently,...

    Paula Unzueta-Larrinaga, Rocío Barrena-Barbadillo, ... Leyre Urigüen in Molecular Neurobiology
    Article Open access 28 April 2023
  8. The speed of adaptation is dependent on the load type during target reaching by intact human subjects

    When lifting or moving a novel object, humans are routinely able to quickly characterize the nature of the unknown load and swiftly achieve the...

    Keonyoung Oh, William Zev Rymer, Junho Choi in Experimental Brain Research
    Article 16 August 2021
  9. [1-11C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjects

    Background

    Reduced clearance of cerebrospinal fluid (CSF) has been suggested as a pathological feature of Alzheimer’s disease (AD). With extensive...

    Neel H. Mehta, **uyuan Wang, ... Mony J. de Leon in Fluids and Barriers of the CNS
    Article Open access 02 April 2024
  10. Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

    Background

    Growing evidence has demonstrated that DNA methylation (DNAm) plays an important role in Alzheimer’s disease (AD) and that DNAm differences...

    Wei Zhang, Juan I. Young, ... Lily Wang in Alzheimer's Research & Therapy
    Article Open access 10 April 2023
  11. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects

    Purpose

    To evaluate the clinical feasibility and tolerability of large volume subcutaneous delivery at different injection depths for lean and...

    **angnan Dang, Han Shih, ... David S. Collins in Pharmaceutical Research
    Article 05 March 2024
  12. Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease

    Background

    This study investigated plasma biomarkers for neuroinflammation associated with Alzheimer’s disease (AD) in subjects with preclinical AD...

    Samantha Prins, Marieke L. de Kam, ... Geert Jan Groeneveld in Alzheimer's Research & Therapy
    Article Open access 03 August 2022
  13. Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis

    Individuals with prodromal symptoms of Lewy body disease (LBD), such as rapid eye movement sleep behavior disorder (RBD), often showed imaging...

    Makoto Hattori, Keita Hiraga, ... Masahisa Katsuno in npj Parkinson's Disease
    Article Open access 26 April 2023
  14. Comparison of pharmacokinetics and safety of albuvirtide in healthy subjects after intravenous drip and bolus injection

    Albuvirtide (ABT) is the first long-acting HIV fusion inhibitor developed in China, blocking the invasion of HIV-1 virus into target cells. This...

    Huiling Qin, Cheng Yao, ... Jun Ye in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 03 August 2023
  15. On the Correlations of Gray Matter with Schizotypy in Mentally Healthy Subjects

    We analyzed the relationships between morphometric characteristics of brain gray matter and schizotypy. Mentally healthy subjects ( n =164, age 18-35...

    I. S. Lebedeva, A. S. Tomyshev, E. V. Pechenkova in Bulletin of Experimental Biology and Medicine
    Article 01 June 2023
  16. Physiological Support of Goal-Directed Activity in Human

    The effectiveness of goal-directed human behavior and the processes underlying organization of such activity are the subjects of various biomedical...

    A. V. Klimenko, S. S. Pertsov in Bulletin of Experimental Biology and Medicine
    Article 01 November 2023
  17. Evaluation of serum miRNAs expression in frail and robust subjects undergoing multicomponent exercise protocol (VIVIFRAIL)

    Background

    Frailty, defined as physical performance impairment, is a common condition in older adults and can anticipate the development of...

    Simone Agostini, Roberta Mancuso, ... Mario Clerici in Journal of Translational Medicine
    Article Open access 02 February 2023
  18. ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics

    Abstract Purpose

    AlzeCure Pharma AB is develo** novel positive allosteric modulators of Trk-receptors for treatment of Alzheimer’s disease,...

    Boel Nilsson, Johan Bylund, ... Märta Segerdahl in European Journal of Clinical Pharmacology
    Article Open access 14 February 2024
  19. Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial

    Background

    Administration of lipopolysaccharide (LPS) from Gram-negative bacteria, also known as the human endotoxemia model, is a standardized and...

    Vincent Millischer, Matthias Heinzl, ... Lilly Schwieler in Journal of Neuroinflammation
    Article Open access 17 July 2021
Did you find what you were looking for? Share feedback.